Synthesis, Molecular docking, Antioxidant, Anti-TB, and Potent MCF-7
Anticancer Studies of Novel Aryl-carbohydrazide Analogues

Bapu      R. Thorat; Suraj      N. Mali; Rahul      R. Wagh; Ramesh      S. Yamgar

doi:10.2174/1573409918666220610162158

Abstract

Background: Hydrazide-hydrazone-based compounds are reported for their wider pharmacological potentials.

Methods: In the present work, we synthesized 10 new Schiff-based-aryl-carbohydrazide (3a-3e) and (4a-4e) analogues and characterized further using standard spectroscopic techniques including NMR, mass and FT-IR. Moreover, all synthesized compounds were subjected to in vitro anti-TB, anti-microbial, antioxidant and anti-MCF-7 cell line studies.

Results: Our results suggested that compounds have strong potencies against studied microbial species (such as 3a, 3b and 3c, (anti-TB activity: MIC value of 1.6 μg/mL; 3c:80.23 % inhibition at 200 μg/mL against MCF-7). Synthesized compounds (3a-3e) and (4a-4e) were also retained with higher docking scores than standards like ciprofloxacin; when studied for their molecular docking analysis against common anti-bacterial (pdb id:1d7u; 3a: -4.909 kcal/mol), common anti-fungal (pdb id:1ai9; 3b: -6.122 kcal/mol) and enoyl acyl reductase enzyme (pdb id:2x22; 3c: docking score: -4.194 kcal/mol)) targets.

Conclusion: Thus, considering promising results for Schiff-based-aryl-carbohydrazides, these compounds may emerge as a new class for developing potent anti-microbial agents in the near future.

Keywords: carbohydrazide, Anti-oxidant activity, Anti-cancer, in-silico analysis, Anti-microbial activity, synthesis.

[1] 
WHO. Tuberculosis  Available from: http://www.who.int/topics/tuberculosis/en/
[2] 
Angelova, V.T.; Valcheva, V.; Vassilev, N.G.; Buyukliev, R.; Momekov, G.; Dimitrov, I.; Saso, L.; Djukic, M.; Shivachev, B. Antimycobac-terial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold. Bioorg. Med. Chem. Lett.,  2017, 27(2), 223-227.
[http://dx.doi.org/10.1016/j.bmcl.2016.11.071] [PMID:  27914798] 
[3] 
Lemke, T.L.; Williams, D.A.; Roche, V.F.; Zito, S.W. Foye’s principles of medicinal chemistry, 7th ed; Wolters Kluwer: New Delhi, 2013, p. 1177.
[4] 
Bhat, M.A.; Al-Omar, M.A. Synthesis, characterization, and in vitro anti-Mycobacterium tuberculosis activity of terpene Schiff bases. Med. Chem. Res.,  2013, 22(9), 4522-4528.
[http://dx.doi.org/10.1007/s00044-012-0458-3] 
[5] 
Paidi, K.R.; Tatipamula, V.B.; Kolli, M.K.; Pedakotla, V.R. Benzohydrazide incorporated imidazo [1, 2-b] pyridazine: Synthesis, characteri-zation and in vitro anti-tubercular activity. Int. J. Chem. Sci.,  2017, 15(3), 172.
[6] 
Tseng, C.H.; Tung, C.W.; Wu, C.H.; Tzeng, C.C.; Chen, Y.H.; Hwang, T.L.; Chen, Y.L. Discovery of indeno [1, 2-c] quinoline derivatives as potent dual antituberculosis and anti-Inflammatory agents. Molecules,  2017, 22(6), 1001.
[http://dx.doi.org/10.3390/molecules22061001] [PMID:  28621733] 
[7] 
Mali, S.N.; Chaudhari, H.K. Computational studies on imidazo [1,2-a] pyridine-3-carboxamide analogues as antimycobacterial agents: Common pharmacophore generation, atom-based 3DQSAR, molecular dynamics simulation, qikprop, molecular docking and prime MMGBSA approaches. Open Pharm. Sci. J.,  2018, 5(1), 12-23.
[http://dx.doi.org/10.2174/1874844901805010012] [http://dx.doi.org/10.2174/1874844901805010012] 
[8] 
Pavan, F.R. da S Maia, P.I.; Leite, S.R.; Deflon, V.M.; Batista, A.A.; Sato, D.N.; Franzblau, S.G.; Leite, C.Q. Thiosemicarbazones, semi-carbazones, dithiocarbazates and hydrazide/hydrazones: Anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur. J. Med. Chem.,  2010, 45(5), 1898-1905.
[http://dx.doi.org/10.1016/j.ejmech.2010.01.028] [PMID:  20163897] 
[9] 
Nusrath Unissa, A.; Hanna, L.E.; Swaminathan, S. A note on derivatives of isoniazid, Rifampicin, and pyrazinamide showing activity against resistant Mycobacterium tuberculosis. Chem. Biol. Drug Des.,  2016, 87(4), 537-550.
[http://dx.doi.org/10.1111/cbdd.12684] [PMID:  26613382] 
[10] 
Sriram, D.; Yogeeswari, P.; Vyas, D.R.K.; Senthilkumar, P.; Bhat, P.; Srividya, M. 5-Nitro-2-furoic acid hydrazones: Design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures. Bioorg. Med. Chem. Lett.,  2010, 20(15), 4313-4316.
[http://dx.doi.org/10.1016/j.bmcl.2010.06.096] [PMID:  20615698] 
[11] 
Velezheva, V.; Brennan, P.; Ivanov, P.; Kornienko, A.; Lyubimov, S.; Kazarian, K.; Nikonenko, B.; Majorov, K.; Apt, A. Synthesis and antituberculosis activity of indole-pyridine derived hydrazides, hydrazide-hydrazones, and thiosemicarbazones. Bioorg. Med. Chem. Lett.,  2016, 26(3), 978-985.
[http://dx.doi.org/10.1016/j.bmcl.2015.12.049] [PMID:  26725953] 
[12] 
Coelho, T.S.; Cantos, J.B.; Bispo, M.L.F.; Gonçalves, R.S.B.; Lima, C.H.S.; da Silva, P.E.A.; Souza, M.V. In vitro anti-mycobacterial activity of (E)-N′-(monosubstituted-benzylidene) isonicotinohydrazide derivatives against isoniazid-resistant strains. Infect. Dis. Rep.,  2012, 4(1), e13.
[http://dx.doi.org/10.4081/idr.2012.e13] [PMID:  24470920] 
[13] 
de Souza, M.V.N. Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products. Fitoterapia,  2009, 80(8), 453-460.
[http://dx.doi.org/10.1016/j.fitote.2009.07.010] [PMID:  19698768] 
[14] 
Smieja, M.J.; Marchetti, C.A.; Cook, D.J.; Smaill, F.M. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst. Rev.,  2000, (2), CD001363.
[http://dx.doi.org/10.1002/14651858.CD001363] [PMID:  10796642] 
[15] 
Akolo, C.; Adetifa, I.; Shepperd, S.; Volmink, J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst. Rev.,  2010, (1), CD000171.
[http://dx.doi.org/10.1002/14651858.CD000171.pub3] [PMID:  20091503] 
[16] 
Schnappinger, D.; Ehrt, S.; Voskuil, M.I.; Liu, Y.; Mangan, J.A.; Monahan, I.M.; Dolganov, G.; Efron, B.; Butcher, P.D.; Nathan, C.; Schoolnik, G.K. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment. J. Exp. Med.,  2003, 198(5), 693-704.
[http://dx.doi.org/10.1084/jem.20030846] [PMID:  12953091] 
[17] 
Mathew, B.; Suresh, J.; Ahsan, M.J.; Mathew, G.E.; Usman, D.; Subramanyan, P.N.; Safna, K.F.; Maddela, S. Hydrazones as a privileged structural linker in antitubercular agents: A review. Infect. Disord. Drug Targets,  2015, 15(2), 76-88.
[http://dx.doi.org/10.2174/1871526515666150724104411] [PMID:  26205803] 
[18] 
Belkheiri, N.; Bouguerne, B.; Bedos-Belval, F.; Duran, H.; Bernis, C.; Salvayre, R.; Nègre-Salvayre, A.; Baltas, M. Synthesis and antioxidant activity evaluation of a syringic hydrazones family. Eur. J. Med. Chem.,  2010, 45(7), 3019-3026.
[http://dx.doi.org/10.1016/j.ejmech.2010.03.031] [PMID:  20403645] 
[19] 
Rane, R.A.; Telvekar, V.N. Synthesis and evaluation of novel chloropyrrole molecules designed by molecular hybridization of common pharmacophores as potential antimicrobial agents. Bioorg. Med. Chem. Lett.,  2010, 20(19), 5681-5685.
[http://dx.doi.org/10.1016/j.bmcl.2010.08.026] [PMID:  20800487] 
[20] 
Bawa, S.; Kumar, S.; Drabu, S.; Kumar, R. Synthesis and antimicrobial activity of 2-chloro-6- methylquinoline hydrazone derivatives. J. Pharm. Bioallied Sci.,  2009, 1(1), 27-31.
[http://dx.doi.org/10.4103/0975-7406.62683] 
[21] 
Kaplancikli, Z.A.; Altintop, M.D.; Özdemir, A.; Turan-Zitounia, G.; Khan, S.I.; Tabanca, N. Synthesis and biological evaluation of some hydrazone derivatives as anti-inflammatory agents. Lett. Drug Des. Discov.,  2012, 9, 310-315.
[http://dx.doi.org/10.2174/157018012799129828] [http://dx.doi.org/10.2174/157018012799129828] 
[22] 
Hu, W.X.; Zhou, W.; Xia, C.N.; Wen, X. Synthesis and anticancer activity of thiosemicarbazones. Bioorg. Med. Chem. Lett.,  2006, 16(8), 2213-2218.
[http://dx.doi.org/10.1016/j.bmcl.2006.01.048] [PMID:  16458509] 
[23] 
Congiu, C.; Onnis, V. Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents. Bioorg. Med. Chem.,  2013, 21(21), 6592-6599.
[http://dx.doi.org/10.1016/j.bmc.2013.08.026] [PMID:  24071449] 
[24] 
Vicini, P.; Incerti, M.; La Colla, P.; Loddo, R. Anti-HIV evaluation of benzo[d]isothiazole hydrazones. Eur. J. Med. Chem.,  2009, 44(4), 1801-1807.
[http://dx.doi.org/10.1016/j.ejmech.2008.05.030] [PMID:  18614259] 
[25] 
Rocha, L.T.S.; Costa, K.A.; Oliveira, A.C.P.; Nascimento, E.B., Jr; Bertollo, C.M.; Araújo, F.; Teixeira, L.R.; Andrade, S.P.; Beraldo, H.; Coelho, M.M. Antinociceptive, antiedematogenic and antiangiogenic effects of benzaldehyde semicarbazone. Life Sci.,  2006, 79(5), 499-505.
[http://dx.doi.org/10.1016/j.lfs.2006.01.027] [PMID:  16600310] 
[26] 
Krishnan, K.; Prathiba, K.; Jayaprakash, V.; Basu, A.; Mishra, N.; Zhou, B.; Hu, S.; Yen, Y. Synthesis and ribonucleotide reductase inhibi-tory activity of thiosemicarbazones. Bioorg. Med. Chem. Lett.,  2008, 18(23), 6248-6250.
[http://dx.doi.org/10.1016/j.bmcl.2008.09.097] [PMID:  18976907] 
[27] 
Thanigaimalai, P.; Lee, K.C.; Sharma, V.K.; Roh, E.; Kim, Y.; Jung, S.H. Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition. Bioorg. Med. Chem. Lett.,  2011, 21(12), 3527-3530.
[http://dx.doi.org/10.1016/j.bmcl.2011.04.146] [PMID:  21601449] 
[28] 
Thomas, K.D.; Adhikari, A.V.; Telkar, S.; Chowdhury, I.H.; Mahmood, R.; Pal, N.K.; Row, G.; Sumesh, E. Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents. Eur. J. Med. Chem.,  2011, 46(11), 5283-5292.
[http://dx.doi.org/10.1016/j.ejmech.2011.07.033] [PMID:  21907466] 
[29] 
Bukowski, L.; Janowiec, M. 1-Methyl-1H-2-imidazo[4,5-b]pyridinecarboxylic acid and some of its derivatives with suspected antitubercu-lotic activity. Pharmazie,  1996, 51(1), 27-30.
[http://dx.doi.org/10.1002/chin.199630179] [PMID:  8999430] 
[30] 
Küçükgüzel, Ş.G.; Rollas, S.; Küçükgüzel, İ.; Kiraz, M. Synthesis and Antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur. J. Med. Chem.,  1999, 34(12), 1093-1100.
[http://dx.doi.org/10.1016/S0223-5234(99)00129-4] 
[31] 
Cocco, M.T.; Congiu, C.; Onnis, V.; Pusceddo, M.C.; Schivo, M.L.; De Logu, A. Synthesis and antimycobacterial activity of some isonico-tinoylhydrazones. Eur. J. Med. Chem.,  1999, 34(12), 1071-1076.
[http://dx.doi.org/10.1016/S0223-5234(99)00124-5] 
[32] 
Bukowski, L.; Janowiec, M.; Zwolska-Kwiek, Z.; Andrzejczyk, Z. Synthesis and some reactions of 2-acetylimidazo[4,5-b]pyridine. An-tituberculotic activity of the obtained compounds. Pharmazie,  1999, 54(9), 651-654.
[PMID:  10522269] 
[33] 
John, S.F.; Aniemeke, E.; Ha, N.P.; Chong, C.R.; Gu, P.; Zhou, J.; Zhang, Y.; Graviss, E.A.; Liu, J.O.; Olaleye, O.A. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb.),  2016, 101S, S73-S77.
[http://dx.doi.org/10.1016/j.tube.2016.09.025] [PMID:  27856197] 
[34] 
Cheng, F.; Li, W.; Zhou, Y.; Shen, J.; Wu, Z.; Liu, G.; Lee, P.W.; Tang, Y. admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. J. Chem. Inf. Model.,  2012, 52(11), 3099-3105.
[http://dx.doi.org/10.1021/ci300367a] [PMID:  23092397] 
[35] 
Abate, G.; Mshana, R.N.; Miörner, H. Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis.,  1998, 2(12), 1011-1016.
[PMID:  9869118] [PMID:  9869118] 
[36] 
Shimamura, T.; Sumikura, Y.; Yamazaki, T.; Tada, A.; Kashiwagi, T.; Ishikawa, H.; Matsui, T.; Sugimoto, N.; Akiyama, H.; Ukeda, H. Ap-plicability of the DPPH assay for evaluating the antioxidant capacity of food additives - inter-laboratory evaluation study -. Anal. Sci.,  2014, 30(7), 717-721.
[http://dx.doi.org/10.2116/analsci.30.717] [PMID:  25007929] 
[37] 
Mali, S.N.; Pandey, A.; Thorat, B.R.; Lai, C.H. Multiple 3D-and 2D-quantitative structure–activity relationship models (QSAR), theoretical study and molecular modeling to identify structural requirements of imidazopyridine analogues as anti-infective agents against tuberculosis. Struct. Chem.,  2022, 33, 679-694.
[http://dx.doi.org/10.1007/s11224-022-01879-2] 
[38] 
Nagre, D.T.; Thorat, B.R.; Mali, S.N.; Farooqui, M.; Agrawal, B. Experimental and computational insights into bis-indolylmethane deriva-tives as potent antimicrobial agents inhibiting 2, 2-dialkylglycine decarboxylase. Curr. Enzym. Inhib.,  2021, 17(3), 204-216.
[http://dx.doi.org/10.2174/1573408017666210914105731] 
[39] 
(a) Protein Database Bank. Glide; Schrödinger, LLC: NY, 2021. Available from: https://www.rcsb.org/
[40] 
Mali, S.N.; Pandey, A. Unveiling naturally occurring green tea polyphenol epigallocatechin-3-gallate (EGCG) targeting mycobacterium DPRE1 for anti-tb drug discovery. Eng. Proc.,  2021, 11, 31.
[http://dx.doi.org/10.3390/ASEC2021-11185] 
[41] 
Ghosh, S.; Mali, S.N.; Bhowmick, D.N.; Pratap, A.P. Neem oil as natural pesticide: Pseudo ternary diagram and computational study. J. Indian Chem. Soc.,  2021, 98(7), 100088.
[http://dx.doi.org/10.1016/j.jics.2021.100088] 
[42] 
Desale, V.J.; Mali, S.N.; Thorat, B.R.; Yamgar, R.S. Synthesis, admetSAR predictions, DPPH radical scavenging activity, and potent anti-mycobacterial studies of hydrazones of substituted 4-(anilino methyl) benzohydrazides (Part 2). Curr. Computeraided Drug Des.,  2021, 17(4), 493-503.
[http://dx.doi.org/10.2174/1573409916666200615141047] [PMID:  32538732] 
[43] 
Kshatriya, R.; Shelke, P.; Mali, S.; Yashwantrao, G.; Pratap, A.; Saha, S. Synthesis and evaluation of anticancer activity of pyrazolone ap-pended triarylmethanes (TRAMs). ChemistrySelect,  2021, 6(24), 6230-6239.
[http://dx.doi.org/10.1002/slct.202101083] 
[44] 
Mali, S.N.; Pandey, A. Multiple QSAR and molecular modelling for identification of potent human adenovirus inhibitors. J. Indian Chem. Soc.,  2021, 98(6), 100082.
[http://dx.doi.org/10.1016/j.jics.2021.100082] 
[45] 
Mali, S.N.; Pandey, A. Molecular modeling studies on 2, 4-disubstituted imidazopyridines as anti-malarials: Atom-based 3D-QSAR, molec-ular docking, virtual screening, in silico ADMET and theoretical analysis. J. Comput. Biophys. Chem.,  2021, 20(03), 267-282.
[http://dx.doi.org/10.1142/S2737416521500125] 
[46] 
Chopade, A.R.; Somade, P.M.; Somade, P.P.; Mali, S.N. Identification of anxiolytic potential of niranthin: in-vivo and computational investi-gations. Nat. Prod. Bioprospect.,  2021, 11(2), 223-233.
[http://dx.doi.org/10.1007/s13659-020-00284-8] [PMID:  33175328] 
[47] 
Thorat, B.R.; Mali, S.N.; Rani, D.; Yamgar, R.S. Synthesis, in silico and in vitro analysis of hydrazones as potential antituberculosis agents. Curr. Computeraided Drug Des.,  2021, 17(2), 294-306.
[http://dx.doi.org/10.2174/1573409916666200302120942] [PMID:  32141422] 
[48] 
Chopade, A.R.; Pol, R.P.; Patil, P.A.; Dharanguttikar, V.R.; Naikwade, N.S.; Dias, R.J.; Mali, S.N. An insight into the anxiolytic effects of lignans (phyllanthin and hypophyllanthin) and tannin (corilagin) rich extracts of Phyllanthus amarus: An in silico and in-vivo approaches. Comb. Chem. High Throughput Screen.,  2021, 24(3), 415-422.
[http://dx.doi.org/10.2174/1386207323666200605150915] [PMID:  32503404] 
[49] 
Mali, S.N.; Thorat, B.R.; Gupta, D.R.; Pandey, A. Mini-review of the importance of hydrazides and their derivatives-Synthesis and biologi-cal activity. Engineering Proceedings,  2021, 11(1), 21.
[50] 
Nagre, D.T.; Mali, S.N.; Thorat, B.R.; Thorat, S.A.; Chopade, A.R.; Farooqui, M.; Agrawal, B. Synthesis, in silico potential enzymatic target predictions, pharmacokinetics, toxicity, anti-microbial and anti-inflammatory studies of bis-(2-methylindolyl) methane derivatives. Curr. Enzym. Inhib.,  2021, 17(2), 127-143.
[http://dx.doi.org/10.2174/1573408017666210203203735] 
[51] 
Chopade, A.R.; Pol, R.P.; Patil, P.A.; Dharanguttikar, V.R.; Naikwade, N.S.; Dias, R.J.; Mali, S.N. Pharmacological and in silico investigations of anxiolytic-like effects of phyllanthus fraternus: A probable involvement of GABA-A receptor. Curr. Enzym. Inhib.,  2021, 17(1), 42-48.
[http://dx.doi.org/10.2174/1573408016999201026200650] 
[52] 
Anuse, D.G.; Mali, S.N.; Thorat, B.R.; Yamgar, R.S.; Chaudhari, H.K. Synthesis, SAR, in silico appraisal and anti-microbial study of substi-tuted 2-aminobenzothiazoles derivatives. Curr. Computeraided Drug Des.,  2020, 16(6), 802-813.
[http://dx.doi.org/10.2174/1573409915666191210125647] [PMID:  31820704] 
[53] 
Jadhav, B.S.; Yamgar, R.S.; Kenny, R.S.; Mali, S.N.; Chaudhari, H.K.; Mandewale, M.C. Synthesis, in silico and biological studies of thia-zolyl-2h-chromen-2-one derivatives as potent antitubercular agents. Curr. Computeraided Drug Des.,  2020, 16(5), 511-522.
[http://dx.doi.org/10.2174/1386207322666190722162100] [PMID:  31438831] 
[54] 
Desale, V.J.; Mali, S.N.; Chaudhari, H.K.; Mali, M.C.; Thorat, B.R.; Yamgar, R.S. Synthesis and anti-mycobacterium study on halo-substituted 2-aryl oxyacetohydrazones. Curr. Computeraided Drug Des.,  2020, 16(5), 618-628.
[http://dx.doi.org/10.2174/1573409915666191018120611] [PMID:  31648645] 
[55] 
Anuse, D.G.; Thorat, B.R.; Sawant, S.; Yamgar, R.S.; Chaudhari, H.K.; Mali, S.N. Synthesis, SAR, molecular docking and anti-microbial study of substituted N-bromoamido-2-aminobenzothiazoles. Curr. Computeraided Drug Des.,  2020, 16(5), 530-540.
[http://dx.doi.org/10.2174/1573409915666190902143648] [PMID:  31475902] 
[56] 
Thorat, B.R.; Rani, D.; Yamgar, R.S.; Mali, S.N. Synthesis, spectroscopic, in vitro and computational analysis of hydrazones as potential antituberculosis agents:(part-I). Comb. Chem. High Throughput Screen.,  2020, 23(5), 392-401.
[http://dx.doi.org/10.2174/1386207323999200325125858] [PMID:  32209038] 
[57] 
Mali, S.N.; Chaudhari, H.K. Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR. SAR QSAR Environ. Res.,  2019, 30(3), 161-180.
[http://dx.doi.org/10.1080/1062936X.2019.1573377] [PMID:  30786763] 

Rights & Permissions Print Cite

Article Metrics

3

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573409918666220610162158	Print ISSN 1573-4099
Publisher Name Bentham Science Publisher	Online ISSN 1875-6697

Current Computer-Aided Drug Design

Synthesis, Molecular docking, Antioxidant, Anti-TB, and Potent MCF-7 Anticancer Studies of Novel Aryl-carbohydrazide Analogues

Abstract Play Pause

Related Journals

Related Books

Abstract